Edwards Lifesciences Corporation

Climate Impact & Sustainability Data (2023)

Total Carbon Emissions:39,903 MT CO2e

Scope 3 Emissions:571,975 MT CO2e

Renewable Energy Share:37%

Water Consumption:805,195 m3

Waste Generated:5,612 tons

Achieved a 7% absolute reduction in Scope 1 and 2 GHG emissions over the prior year, and a 13% reduction from our 2021 baseline year.
Received 37% of total energy from renewable sources, up from 23% in the prior year.
All Edwards manufacturing facilities are now ISO 14001:2015 and ISO 45001:2018 certified.
Zero waste-to-landfill in Ireland manufacturing operations in 2023.

87% of employees reported participating in charitable activities within the past 12 months.
100% of senior leadership team reported participation in charitable activities.
Launched the Edwards Patient Support Center (PSC), seeing a 101% increase in inquiries compared to 2022.
All global employees completed unconscious bias training.

In 2023, approximately 90% of the target total direct compensation of our CEO, and an average of 81% of the target total direct compensation of our other Named Executive Officers, was performance-based.
Edwards experienced no cyber breaches or incidents that had a material impact in 2023.
Zero Class 1 field corrective actions in 2023.

Medium-term Goals:

Reduce absolute scope 1 and 2 greenhouse gas emissions 42% from a 2021 base year and achieve carbon neutrality by 2030
Reduce scope 3 greenhouse gas emission 51.6% per USD of value added by 2030

Short-term Goals:

Reduce recordable workplace injury rates by 35% by 2025
Improve the lives of 2.5 million additional underserved structural heart and critical care patients by the end of 2025

Changing weather patterns may cause business interruptions.
A changing regulatory landscape, such as Europe’s conversion from the 1992 Medical Device Directive to the 2021 Medical Device Regulation.
Cumulative trauma illnesses represent approximately 43% of Edwards’ work-related injuries and illnesses.

Maintaining emergency response systems and business recovery processes.
Incorporating corporate impact factors, such as environmental risk, into our risk assessments.
Using the TCFD’s risk assessment framework to assess risks and determine appropriate mitigation approaches.
Implementing control measures to eliminate or manage hazards and risk, following the National Institute for Occupational Health and Safety’s Hierarchy of Controls.
Aggressive strategies to address ergonomic risks with appropriate prevention and control measures.

Supplier Audits: Rigorous risk-based due diligence for new suppliers; periodic audits of existing suppliers.

Frameworks Used: GRI 2021, SASB Medical Equipment and Supplies, TCFD

Certifications: ISO 14001:2015, ISO 45001:2018

Third-party Assurance: Apex Companies LLC (Scope 1, 2, and 3 GHG emissions)

Initiatives described in the report contribute to these goals.